ARCHIVES

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Changes Deadlines For Two RFAS

July 18, 1997

NCI-Approved Clinical Trials

September 28, 2001

James Doroshow Named NCI Deputy Director, Clinical Research

June 10, 2011

DCPC Board Commits More Than $100 Million To 15-Year Trial Of Low Fat Diet In Women

October 26, 1990

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

Funding Opportunities.

May 24, 2002